false 0000727346 0000727346 2024-11-20 2024-11-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 20, 2024.

 

SELECTIS HEALTH, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Utah   0-15415   87-0340206
(State or other jurisdiction   Commission File   (I.R.S. Employer
of incorporation)   Number   Identification number)

 

8480 E. Orchard Road, Ste. 4900, Greenwood Village, CO   80111
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (720) 680-0808

 

 

(Former name or former address, if changed since last report)

 

Written communications pursuant to Rule 425 under the Securities Act
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class   Trading Symbol   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 
 

 

ITEM 4.01. CHANGES IN REGISTRANT’S INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS

 

(a) Termination of Independent Registered Public Accounting Firm Relationship

 

Effective November 20, 2024 the Company’s independent registered public accountants Marcum LLP, terminated their relationship with the company as its independent auditors.

 

In the period from Marcum LLP’s appointment in 2022 until the date of this Report, there were no disagreements with Marcum LLP on any matters of accounting principles or practices, financial statement disclosure, or auditing scope and procedures which, if not resolved to the satisfaction of Marcum LLP, would have caused Marcum LLP to make reference to the matter in its report on the Company’s financial statements; and there were no reportable events as defined in Item 304(a)(1)(v) of Regulation S-K. Marcum LLP, issued audit reports on our financial statements as of and for the years ended December 31, 2023 and 2022, which reports each included an explanatory paragraph concerning the Company’s ability to continue as a going concern.

 

The Company has provided Marcum LLP with a copy of the above disclosures. Attached as Exhibit 16.1 is a copy of Marcum LLP’s letter, dated November 22, 2024, stating its agreement with such statements.

 

The Company has yet to engage a new independent registered public accounting firm.

 

Item 9.01 Financial Statements and Exhibits

 

(a)Financial statements of businesses acquired.

 

Not applicable

 

(b)Pro forma financial information.

 

Not applicable

 

(c)Shell company transactions.

 

Not applicable

 

(d)Exhibits

 

  Item   Title
       
  16.1   Pursuant to Item 304(a)(1) of Regulation S-K, the Registrant herewith files the letter of Marcum LLP, former accountants to the Company.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

      Selectis Health, Inc.
      (Registrant)
       
Dated: November 22, 2024   /s/ Adam Desmond
      Adam Desmond, CEO
       

 

 

 

 

Exhibit 16.1

 

 

 

 

v3.24.3
Cover
Nov. 20, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 20, 2024
Entity File Number 0-15415
Entity Registrant Name SELECTIS HEALTH, INC.
Entity Central Index Key 0000727346
Entity Tax Identification Number 87-0340206
Entity Incorporation, State or Country Code UT
Entity Address, Address Line One 8480 E. Orchard Road
Entity Address, Address Line Two Ste. 4900
Entity Address, City or Town Greenwood Village
Entity Address, State or Province CO
Entity Address, Postal Zip Code 80111
City Area Code (720)
Local Phone Number 680-0808
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false

Selectis Health (PK) (USOTC:GBCS)
Historical Stock Chart
Von Dez 2024 bis Jan 2025 Click Here for more Selectis Health (PK) Charts.
Selectis Health (PK) (USOTC:GBCS)
Historical Stock Chart
Von Jan 2024 bis Jan 2025 Click Here for more Selectis Health (PK) Charts.